News Center

Home page

Peak Report

News reports

Selected Essay on Quality Month of Pharmaceutical Company

Release time:

2022-12-04

drugs

during the national day, a relative in the village came to me with two boxes of metformin hydrochloride englijing tablets, saying that one of his two boxes of drugs was prepared by the hospital and the other was bought at the pharmacy. The drugstore recommended another one because it did not have the kind that the hospital matched, saying that the effect was the same, but he always felt that the effect was not good after taking it back and wanted to ask whether the psychological effect or the drug effect was really different.

For most drug users, the intuitive effect after taking drugs is all the drug quality connotation they can understand. The drug market is full of flowers. There are dozens or even hundreds of manufacturers of the same drug. It is really difficult for consumers to judge which is better. In order to improve the quality of drugs, pharmaceutical manufacturers need to ensure their effectiveness, safety, stability and uniformity to the greatest extent. In addition, through the reasonable control of production costs, the market competitiveness of products should be enhanced to ensure the economy of drug use by consumers. On my first day at the pharmaceutical factory, I was trained on the concept of

drug quality is not tested, but produced " . In my work practice, I have deeply realized that the quality of drugs is not only based on the test results, but also on the test reports. Changes, deviations, complete quality system, qualified production personnel, raw materials provided by qualified suppliers, confirmed production equipment, good environment, and standardized implementation of production operating procedures, each link is an important part of drug quality. Any changes in production, any fluctuations that deviate from established parameters, need to be addressed through risk assessment. There is a long way to go to ensure the quality of drugs and ensure the life, health and safety of the drug user. The peak is making continuous efforts and striving forward ... With the encouragement of innovative drugs at the national policy level and the comprehensive promotion of drug consistency evaluation, drug manufacturers are facing the survival of the fittest, and the phenomenon of good and bad drugs on the market will come to an end. As a member of the drug production process, I will do my best to work with other members of the team to earnestly perform my duties and effectively ensure the safety of each drug. I firmly believe that the upcoming development of the peak brand metformin hydrochloride nglijing tablets will become The first choice for the majority of diabetic patients.

(Ye Ke, Workshop G01

, Xinjinxi Factory Area)

During the quality activity month of Flight Inspection

, the pharmaceutical company carried out a series of colorful activities around quality, such as hanging banners in the factory area, holding knowledge lectures, setting up learning groups, collecting short videos, and answering knowledge.

coincided with the on-site verification of the

CM082

project by the national bureau and provincial bureau inspectors during the quality month activities. After the inspection, the person in charge of quality sighed and said: "Our employees are becoming more and more confident when facing the inspection. " Looking back on the inspections experienced these years, I also feel a lot of emotion. When I first checked, I was afraid that the inspector would point out the defects, always thinking that the fewer defects, the better. This incorrect mentality has led me to always worry about gains and losses when facing inspections, and regard reducing the lack of clauses as my first priority. Be complacent because there are few defective clauses, and upset because there are many defective clauses. In the face of inspection will be anxious, answer the inspector's questions will be nervous, and even afraid to answer questions. After flight inspection and verification, rectification and correction, our quality system is gradually complete. The gradual improvement of the document system also gave me confidence, because every step of the operation and records are based on evidence, and I can answer the inspector's questions in an orderly manner against the internal documents. Slowly, I changed my position from being inspected to being a student, and the inspector was my best teacher. Now, for their own management difficulties, I will take the initiative to consult the teacher, hoping to get some advice from the teacher. The examination teacher will often patiently answer my questions and answer my doubts. Look! The inspector is not so terrible as imagined, but a group of persistent and lovely people.

As the saying goes

gold is not barefoot, no one is perfect " , there is no perfect enterprise in the world, and every enterprise has some defects and deficiencies more or less. As long as we do our job well, do not cheat or cheat, sincerely and humbly listen to the teacher's teachings, frankly accept the defects pointed out by the teacher, understand and actively and thoroughly rectify, our quality management will become more and more comprehensive. However, there is no end to quality management. It still requires generations of quality people to strengthen their beliefs, face quality management with the spirit of craftsmen, and contribute their own strength to achieve a century-old peak. We 've been on the road! ( QC

A Fu Junli)

My post and my quality responsibility

The first sight of this topic aroused my deep thinking. As a workshop manager, facing the production line, how should the quality responsibility of this post be reflected and continued? In fact, the quality responsibility of the post is the responsibility of the whole staff, while I play the role of supervising, executing, summarizing, deepening and training the executor of a circular process.

, as the executor, should fully interpret the contents of the existing documents, sort out the key quality control points of each product, each post and each equipment operation from the documents, and strengthen the memory of the operators in the training, so as to avoid the existing irregularities that have been found and have countermeasures as much as possible in the subsequent production. For example, according to the pipeline design of the preparation system, it is necessary to confirm that the bottom valve of the tank is closed before use after cleaning and sterilization. If it is not closed, the preparation operation should be stopped, and there are regulations in the document and records should be formed to effectively prevent leakage accidents.

Secondly, during the inspection process, with the interpretation of existing documents, communicate effectively with employees, and analyze potential problems in the production operation process such as process and equipment from the perspective of employees, or problems that employees have found but have not formed documents and records. For example, the newly purchased high-speed labeling machine of eye drops production line, after communicating with the operators during the on-site inspection of the production process, found that attention should be paid to whether the labeling position and printing position of the label drift after label replacement. After the ribbon is replaced, check and confirm the printing effect and whether the ribbon position is not correct. When the production process is stopped, the roller products entering the labeling machine need to be empty. There is no description of relevant contents in the troubleshooting of

manufacturer's data. They are all summarized by the workshop according to the actual operation process and confirm whether other labeling machines have the same problems. These precautions are added to the standard operating procedures of labeling machines to prevent the occurrence of such problems. The same applies to other equipment. During operation, attention should be paid to whether changes will be caused by similar replacement of packaging materials, materials or components.

Finally, as managers, they should make an in-depth analysis of the problems found in the inspection, add inspection or operation contents to the corresponding documents and records after summarizing, then carry out timely training, and confirm the implementation and elimination measures in the future inspection. In this way, a cycle of supervision, implementation, summary, deepening and training is formed, and the quality responsibility is continued in the form of documents and records.

The responsibility for quality is endless, and it is always necessary to set the quality policy of the enterprise

" to pursue excellent quality; to be a high-quality medicine for the benefit of human society! "is printed in the mind, keep learning and updating, and be the continuator of quality responsibility! (Preparation Workshop

Fang Ling)

More information

Yunnan peak through the safety standard secondary acceptance

On March 21, Yunnan Jianfeng Cement Company successfully passed the evaluation and acceptance of secondary enterprises for safety production standardization. On the same day, a review team composed of leaders of the Yunnan Provincial Work Safety Supervision Bureau and relevant experts reviewed the implementation of the establishment of Yunnan Jianfeng safety production standardization secondary enterprises. According to the 13 elements involved in the "Standard for Assessment and Rating of Safety Production Standardization in Cement Enterprises", the review team conducted strict assessment and scoring item by item through grouping to check the site and review the data, and finally determined that Yunnan Peak passed the standard acceptance of safety standardization secondary enterprises. Yunnan Jianfeng has always attached great importance to safety production. After passing the three-level safety standard enterprise review in 2015, in order to raise the level of enterprise safety management to a new level, in 2016, it began to create secondary safety standardization. Over the past year, Yunnan Jianfeng has insisted on taking the creation of secondary safety standards as the top priority of production and operation management, and has formulated an implementation plan for production safety standardization in accordance with the requirements of national standardization norms. the content covers production safety responsibility system, education and training, safety inspection, safety facilities management and other safety production management standards, systems and post safety operation procedures, while further strengthening daily safety inspection and regularly organizing emergency plan drills, strengthen the investigation and rectification of potential safety hazards and the supervision of important hazard sources, and further consolidate the foundation of enterprise safety production management. After the review, Zhou Jiping, general manager of Yunnan Jianfeng, said that Yunnan Jianfeng will take this standard as a new starting point. On the basis of consolidating the accident-free achievements in production safety for two consecutive years, it will conscientiously implement the main responsibility of production safety and cultivate

2020

07-30

Pharmaceutical Company Invests in Beihui Bio-Peak Pharmaceutical Plate to Expand its Territory

News from our newspaper On February 28, the 10th meeting of the 9th Board of Directors of the Group Company reviewed and approved the "Proposal on Foreign Investment of Subsidiaries" and the "Proposal on Authorizing the Chairman of the Board of Directors." On the same day, Jianfeng Pharmaceutical signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and the "Performance Commitment Compensation Agreement" with relevant parties. It is planned to use Beijing Huibaoyuan Biotechnology Co., Ltd. (Beihui Biotechnology) and its holding subsidiary Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd. (Guanghui Pharmaceutical) as a platform to jointly carry out new drug research and development, drug production and operation and other pharmaceutical business cooperation. Beihui Biological formerly known as Beijing Huibaoyuan Biotechnology Co., Ltd. The company has strong capabilities in new drug research and development. The actual controller is James Zhou (Zhou Hua), a returned entrepreneurial Ph.D. from Yale University in the United States, and hired Professor Zheng Yongqi from Yale University in the United States as the director of the Huibaoyuan Science and Technology Committee, focusing on anti-tumor and liver disease research. Through the cooperation with Yale University, we have obtained the patent authorization and commercial development license of the new anti-cancer chemical drug trasatabine (trokacitabine)(which has obtained the national new drug clinical approval in August 2016), the anti-hepatitis B chemical drug Crevudine (Clevudine). Guangxi Huibaoyuan Pharmaceutical Technology Co., Ltd., a subsidiary of Beihui Biology, is located in the third international park "China-Malaysia Qinzhou Industrial Park" jointly built by the Chinese government and foreign governments in Guangxi. It covers an area of 214.46 mu and has production workshops for multiple dosage forms such as percolation, tincture, solid preparations and liquid preparations.

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Fit" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original division model, combines all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Peak health marketing and a new "play"

Building a New System, Flattening Management, Spike Health Marketing, New "Way to Work" On February 17, Spike Health Technology Company held a sales meeting to integrate and adjust the construction of a new marketing system and deploy and implement the 2017 sales work. Chen Daiyou, general manager of Health Technology Company, carefully explained and answered the marketing system construction and sales management assessment methods at the meeting, and reached a consensus on unifying thinking. The sales business of Health Technology Company involves three categories: health care products, plant extracts and Chinese herbal pieces. The product attributes and categories are different, and the product sales channels are diversified. In order to facilitate market expansion and adapt to the rapid response to market changes, the Company focuses on key products, key channels and key markets, adjusts the original business model, unifies all sales businesses of the Company, establishes a marketing center, and centralizes and unifies flat management. At the meeting, the Health Technology Company issued the "2017 Sales Management Assessment Measures", which takes sales performance as the leading factor, defines the sales staff's business expenses and market expansion support policies, implements quarterly and annual assessment of sales targets, and directly links the assessment of the progress of sales staff's target tasks with monthly income. After two-way selection, adjustment and implementation of sales positions and target tasks, all sales staff of Health Technology Company have signed a sales economic responsibility system. Chen Daiyou hopes that marketers will build confidence to meet the challenges and grow and progress together with the enterprise. At the same time, he said that the health technology company will focus on strengthening the construction and cultivation of the sales team, and carry out training, learning and experience sharing in various ways, so as to improve the business ability and level of the sales team. (Spike Health)

2020

07-31

Accident-free factory creation enters "second season"

At the beginning of the new year, a major "highlight" of the company's safety and environmental protection management in recent years-the "second quarter" of the establishment of a safety and environmental protection accident-free factory has also begun. Safety and environmental protection accident-free factory creation activities are an important measure for the company to improve the level of on-site management. The first phase of the activity will start on January 1, 2014 and end at the end of 2016 for a period of three years. Since the launch of the activity, all subordinate enterprises of the company have actively organized publicity and training related to safety and environmental protection, strengthened the awareness of safety and environmental protection of all employees, improved the management and operation level of safety and environmental protection; increased investment in safety and environmental protection facilities and equipment; strengthened safety and environmental protection inspection and self-examination and correction of hidden dangers, and timely organized rectification of hidden dangers; strictly assessed the units and relevant responsible persons of the accident, And the accident situation in the group, in order to arouse vigilance and avoid similar accidents. In the past three years, the company's subsidiaries have achieved remarkable results in standardization, safety, and clean operation. Safety and environmental protection accidents have dropped significantly, and no major accidents have occurred, which has effectively promoted the company's safe and civilized production construction. In the 2016 safety and environmental protection accident-free factory establishment assessment conducted a few days ago, a total of 6 units met the accident-free factory standard, of which Yunnan Jianfeng, Jianfeng International Trade and Pharmaceutical Department met the standard for the second consecutive year, and Daye Jianfeng, Qiubin Factory and Cable Company met the standard in the first year. In order to sum up experience and further improve the level of safety and environmental protection management, the Group decided to continue to open

2020

07-31

What will the Chinese Medicine Act bring us?

At the 25th meeting of the Standing Committee of the 12th National People's Congress in December 2016, the the People's Republic of China Chinese Medicine Law (hereinafter referred to as the Chinese Medicine Law) was deliberated and passed, which will come into effect on July 1 this year. As the first comprehensive law that comprehensively and systematically embodies the characteristics of traditional Chinese medicine, the Law of traditional Chinese Medicine clearly stipulates the service of traditional Chinese medicine, the protection and development of traditional Chinese medicine, the training of talents of traditional Chinese medicine, and the scientific research of traditional Chinese medicine. With the change of people's health concept and the continuous innovation of medical mode in recent years, the role of traditional Chinese medicine in health is becoming more and more important. The promulgation of the "Traditional Chinese Medicine Law" has made the development of Chinese medicine more law-based, and it is bound to bring changes to domestic pharmaceutical companies. So, the peak of the pharmaceutical, health products companies will look at the "Chinese Medicine Law", and will have how to deal with it? A few days ago, the reporter interviewed the pharmaceutical companies and peak health technology companies related to the person in charge. What will the Chinese Medicine Act bring us? Reporter: As the general manager of Peak Pharmaceutical, what do you think of the Chinese Medicine Law? Huang Jinlong (Deputy General Manager of the Group Company and General Manager of the Pharmaceutical Company): the Law of traditional Chinese Medicine defines the important position and development policy of traditional Chinese medicine. The state encourages traditional Chinese medicine and western medicine to learn from each other, complement each other, coordinate development, give full play to their respective advantages, and promote the integration of traditional Chinese and western medicine. Traditional Chinese medicine is a huge knowledge system, reflecting the Chinese nation's understanding of life, health and disease. It is precisely because of the distinctive characteristics of Chinese medicine that the Law of Chinese Medicine is used in Chinese medicine clinics, Chinese medicine physicians and doctors.

2020

07-31

< 1...49 50 51...61 > 跳转到页